Page last updated: 2024-08-23

pizotyline and Huntington Disease

pizotyline has been researched along with Huntington Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ellerby, LM; Hughes, RE; Papanikolaou, T; Sarantos, MR	1

Other Studies

1 other study(ies) available for pizotyline and Huntington Disease

Article	Year
Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease. Journal of Huntington's disease, 2012, Volume: 1, Issue:2 Topics: Animals; Apoptosis; Cells, Cultured; Corpus Striatum; Dose-Response Relationship, Drug; Huntington Disease; MAP Kinase Signaling System; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Pizotyline; Treatment Outcome	2012

Article

Year

Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease.

Journal of Huntington's disease, 2012, Volume: 1, Issue:2

Topics: Animals; Apoptosis; Cells, Cultured; Corpus Striatum; Dose-Response Relationship, Drug; Huntington Disease; MAP Kinase Signaling System; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Pizotyline; Treatment Outcome

2012